Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation

OBJECTIVE: To review the pharmacology, clinical efficacy and safety of partial agonists of α4β2 nicotinic acetylcholine receptor. DATA SOURCES: Primary literature and review articles were obtained via a PUBMED search (1988-August 2006) using the key terms smoking cessation, partial agonist alpha4bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, J., Budhiraja, Salil
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Educational Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792622/
https://www.ncbi.nlm.nih.gov/pubmed/20040957
http://dx.doi.org/10.4103/0253-7613.44150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792622/
https://www.ncbi.nlm.nih.gov/pubmed/20040957
http://dx.doi.org/10.4103/0253-7613.44150

Ejemplares similares